Well-differentiated Papillary Mesothelioma of the Pleura: A Series of 24 Cases

American Journal of Surgical Pathology

Volumn 28, Issue 4, 2004, Pages 534-540

  Galateau Sallé, Françoise ^a,b,c   Vignaud, Jean Michel ^b   Burke, Louise ^d   Gibbs, Allen ^e   Brambilla, Elisabeth ^b   Attanoos, Richard ^e   Goldberg, Marcel ^c   Launoy, Guy ^a,c  

^a Department of Pathology CHU Caen ^*

^b CAEN UNIVERSITY HOSPITAL   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d University College Cork and INFANT Centre   (Ireland)

^e LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Asbestos exposure; Immunohistochemistry; Mesothelioma; Pleura; Treatment outcome; Tumor prognosis; Well differentiated papillary mesothelioma

Indexed keywords

ASBESTOS; GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; OCCUPATIONAL EXPOSURE; PAPILLARY MESOTHELIOMA; PLEURA MESOTHELIOMA; PLEURA TUMOR; PROGNOSIS; TREATMENT OUTCOME; TUMOR DIAGNOSIS;

ADULT; AGED; ASBESTOS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PLEURAL NEOPLASMS; PROGNOSIS;

EID: 1842581558     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200404000-00013     Document Type: Article

References (22)

1. Addis BJ, Fox H. Papillary mesothelioma of the ovary. Histopathology. 1983;7:287-298.
2. Barbera V, Rubino M. Papillary mesothelioma of the tunica vaginalis. Cancer. 1957;10:183-189.
3. Bouvier S, Baron O, Nomballais F, et al. Well differentiated papillary mesothelioma of the peritoneum: an attenuated malignant tumor. Review of the literature a propos of a case. Bull Cancer. 1994;81:104-107.
4. Butnor KJ, Sporn TA, Hammar SP, et al. Well-differentiated papillary mesothelioma. Am J Surg Pathol. 2001;25:1304-1309.
5. Chetty R. Well differentiated (benign) papillary mesothelioma of the tunica vaginalis. J Clin Pathol. 1992;45:1029-1030.
6. Churg A, Colby T, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000;24:1183-1200.
7. Cury PM, Butcher DN, Corrin B, et al. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive fibrosis. J Pathol. 1999;189:251-257.
8. Daya D, McCaughey WT. Well differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases. Cancer. 1990;5:292-296.
9. Foyle A, Al-jabi M, McCaughey WT. Papillary peritoneal tumors in women. Am J Surg Pathol. 1981;5:241-249.
10. Galateau-Sallé F, Abdalsamad I, Brambilla E, et al. Interobserver variability in the diagnosis of malignant mesothelioma: preliminary experience of the French Mesothelioma Panel (Mesopath Group) of the National Mesothelioma Survey Program (PNSM), 1998. Mod Pathol. 2000;13:209A.
11. Goldblum J, Hart WR. Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: a clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol. 1995;19: 1124-1137.
12. Henderson DW, Shilkin KB, Whitaker D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol. 1998;110:397-404.
13. Hollinger P, Gaeng D. Simultaneous bilateral spontaneous pneumothorax in a patient with peritoneal and pleural papillary mesothelioma. Respiration. 1997;64:233-235.
14. Kerrigan SA, Tumnir RT, Clement PB, et al. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer. 2002;378-385.
15. Kumaki F, Kawai T, Churg A, et al. Expression of Telomerase Reverse Transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol. 2001;26:365-370.
16. Lammer F, Scherre C, Hacki WH. Well differentiated papillary mesothelioma of the peritoneum: rare, but prognostically important differential diagnosis. Schweiz Med Wochenschr. 1991;22:954-956.
17. Mark EJ, Shin DH. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch A Pathol Anat. 1993;422:445-451.
18. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence in France over the period 1978-2000. Rev Epidemiol Sante Publique. 2003;51:3-30.
19. Sane AC, Roggli VL. Curative resection of a well differentiated papillary mesothelioma of the pericardium. Arch Pathol Lab Med. 1995;11:266-267.
20. Selikoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA. 1964;188:22-26.
21. Shukunami K, Hirabuki S, Kaneshima M, et al. Well-differentiated papillary mesothelioma involving the peritoneal and pleural cavities: successful treatment by local and systemic administration of carboplatin. Tumori. 2000;86:419-421.
22. Yesner R, Hurwitz A. Localized pleural mesothelioma of epithelial type. J Thorac Surg. 1953;26:325-329.